The global escalation in obesity has led to a pronounced increase in the prevalence of metabolic syndrome, a clustering of metabolic disturbances and cardiovascular risk factors that is characterised by abdominal obesity, hyperglycaemia, impaired insulin sensitivity, high blood pressure, abnormal lipids, and a systemic pro-inflammatory state. This evidence concerns the gene INS and Obesity.